Table 4.

Table of Pharmacogenomic Biomarkers in Drug Labeling FDA.

Drug	Therapeutic Area	Biomarker	Labeling Sections
Abacavir	Infectious Diseases	HLA-B	Boxed Warning, Dosage and Administration, Contraindications, Warnings and Precautions
Carbamazepine	Neurology	HLA-B	Boxed Warning, Warnings, Precautions
Clopidogrel	Cardiology	CYP2C19	Boxed Warning, Warnings and Precautions, Clinical Pharmacology
Codeine	Anesthesiology	CYP2D6	Boxed Warning, Warnings and Precautions, Use in Specific Populations, Patient Counseling Information
Lenalidomide	Hematology	Chromosome 5q	Boxed Warning, Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies
Pegloticase	Rheumatology	G6PD	Boxed Warning, Contraindications, Warnings and Precautions, Patient Counseling Information
Rasburicase (1)	Oncology	G6PD	Boxed Warning, Contraindications, Warnings and Precautions
Rasburicase (2)	Oncology	CYB5R	Boxed Warning, Contraindications, Warnings and Precautions
Sodium Nitrite	Toxicology	Nonspecific (Congenital Methemoglobinemia)	Boxed Warning, Warnings and Precautions
Tramadol	Anesthesiology	CYP2D6	Boxed Warning, Warnings, Precautions, Use in Specific Populations, Clinical Pharmacology

Table is based on data reported on the FDA website: https://www.fda.gov/drugs/science-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling.